Acute Polyserositis with Cardiac Tamponade and Bilateral Refractory Pleural Effusion after ChAdOx1 nCoV-19 Vaccination.
Guan-Yi LiChang-Ching LeeChin-Chou HuangPublished in: Vaccines (2022)
The association of SARS-CoV-2 messenger ribonucleic acid vaccines with pericarditis in young adults has been reported. However, data regarding other types of vaccines are extremely limited. We presented a 94-year-old man with rapidly progressive dyspnea and fatigue six days after his first ChAdOx1 nCoV-19 vaccination. Impending cardiac tamponade and bilateral pleural effusion were found. Hence, massive yellowish pericardial and pleural effusion were drained. However, the pleural effusion persisted and pigtail catheters were inserted bilaterally. After serial studies including surgical pleural biopsy, acute polyserositis (pericarditis and pleurisy) was diagnosed. Anti-inflammatory treatment with colchicine and prednisolone was administered. All effusions resolved accordingly. This rare case sheds light on the presentation of ChAdOx1 nCoV-19 vaccine-related acute polyserositis. In conclusion, awareness of this potential adverse event may facilitate the diagnosis for unexplained pericardial or pleural effusion after vaccination.
Keyphrases
- liver failure
- respiratory failure
- sars cov
- rare case
- young adults
- drug induced
- aortic dissection
- left ventricular
- anti inflammatory
- multiple sclerosis
- case report
- heart failure
- hepatitis b virus
- electronic health record
- emergency department
- physical activity
- intensive care unit
- extracorporeal membrane oxygenation
- big data
- machine learning
- sleep quality
- ultrasound guided
- climate change
- coronavirus disease
- mechanical ventilation
- risk assessment
- artificial intelligence
- palliative care
- deep learning
- human health
- fine needle aspiration